Marc Heckmann. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Botulinum Toxins, Type A/therapeutic useClinical Trials as TopicDouble-Blind MethodEndpoint DeterminationEvidence-Based MedicineHumansHyperhidrosis/drug therapyNeuromuscular Agents/therapeutic useReproducibility of ResultsResearch DesignSample Size
Substances: See more » Neuromuscular AgentsBotulinum Toxins, Type A
Year: 2004 PMID: 14726902 DOI: 10.1016/s0190-9622(03)02085-1
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527